Abstract
A new, simple, rapid and stability-indicating RP-HPLC method was developed for the estimation of Emtricitabine (EMT) and Tenofovir disoproxil fumarate (TDF) in pharmaceutical dosage forms and validated. The HPLC method was developed on SHISEIDO C18 column (250 x 4.6 mm i.d, 5μ) using methanol: 20mM phosphate buffer (pH 5.0) in the ratio of 35: 65 v/v at 271 nm. The retention times for EMT and TDF was found to be 2.79 and 4.91 min respectively. Linearity was established in the range of 0.5–1.5 μg/ml and 0.75–2.0 μg/ml for EMT and TDF respectively. The method was precise with %RSD < 2 for both intraday and interday precision. The accuracy of the method was performed over three levels of concentration and the recovery was in the range of 98–102%. The drugs were individually subjected to forced degradation (thermal, photolytic, hydrolytic, and oxidative stress conditions) studies for seven days. EMT showed maximum degradation in acidic medium and TDF showed maximum degradation in basic medium. The method was successfully applied for quantifying the drugs in marketed dosage forms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.